We hope to see you at our ECR webinar on Monday 22 April!

Implementation of reimbursement for genomic testing in Australia: early successes and the pathway ahead - editorial with Prof Andrew Mallett Prof Zornitza Stark A/Prof Jodie Ingles

👏Certainly all the hard work in building evidence and capacity over the past 10 years now paying off with improved access to #diagnosis ! KidGen Melbourne Genomics Health Alliance Australian Genomics

Meet the team: Florencia is a research assistant in Economics of Genomics and Precision Medicine Unit. Her research focuses on early health technology assessment for genomic medicine in transplant care and models of care for genomics services. Florencia loves listening to 🎶 and exploring Melbourne’s top food spots.

3: Association of socioeconomic status and race/ethnicity with disease risk genetic testing awareness ​

Chao Song (Georgia State Uni)

4: NIH Grant Expansion, Ancestral Diversity, and Scientific Collaborations in Genomics Research​

Wei Fu​ (Uni of Louisville​) [3/3]

1: Who Gains When Medicine Becomes More Precise? Evidence from Genomic Testing in Breast Cancer

Jasmin Moshfegh (Stanford Uni)

2: To screen or not to screen: evaluating the costs and benefits of genomic risk pre-screening in public health

Katie Saxby (Uni of Leicester) [2/3]

The IHEA IHEA Economics of Genomics & Precision Medicine Special Interest Group is hosting a webinar on Monday April 22nd focused on early career researchers.

1700 ET / 2200 BST / 0700 AEST

There will be 4 ECR presenters - details below

Register here: healtheconomics.org/event/econ-omi…

#healtheconomics [1/3]

Is diagnostic yield the bottom line in #genetictesting ? Fehlberg et al. identify priority indicators of genomic utility bit.ly/3Q1FfDR #DelphiSurvey Zoe Fehlberg Ilias Goranitis @AndrewMallet8 Prof Zornitza Stark Stephanie Best

☺️ Hugely honoured and completely overwhelmed to receive this award Human Genome Org #HGM24 #HUGO2024 in beautiful Rome! Australian Genomics Victorian Clinical Genetics Services (VCGS) Murdoch Children's Research Institute (MCRI)

[2] Implementation of reimbursement for genomic testing in Australia: early successes and the pathway ahead | Ilias Goranitis Prof Zornitza Stark A/Prof Jodie Ingles | pubmed.ncbi.nlm.nih.gov/38578038/ [3/3] #healtheconomics

[1] Prospective cohort study of genomic newborn screening: BabyScreen+ pilot study protocol | Ilias Goranitis Seb Lunke Prof Zornitza Stark Stephanie Best Dr Riccarda Peters Lilian Downie Dr. Yvonne Bombard | pubmed.ncbi.nlm.nih.gov/38569677/ [2/3] #healtheconomics

👉 Out now in BMJ_Open our BabyScreen+ #genomic newborn screening study protocol 🧬👶

👉bmjopen.bmj.com/content/14/4/e…

Excited to announce our newest team member: Xiuqin Xiong! 👏Xiuqin has recently completed her PhD and will be joining us to research the cost-effectiveness of biomarkers in detecting neurological disorders, as well as preferences for research participation among CALD populations.

Francisco is a PhD candidate at @EiGEN_UOM. His work explores the value, cost effectiveness, and policy implications of providing functional genomic diagnostics for rare disease. In his spare time, you'll find Francisco discovering a new sport 🥊 or finding the best ☕️ on campus.

An essay by Richard H Thaler and yours truly on Danny Kahneman and Amos Tversky, his greatest collaborator.
newyorker.com/books/page-tur…

I’m excited to present and get feedback on my work at the University of Chicago Chronic Diseases and Medical Decision-Making Workshop next week!

We are pleased to announce that the abstract submission for the 45th Annual AHES Conference to be held in Sydney is now open.

The deadline for submission is Sunday, 12th May 2024.

Abstracts should be submitted via the main abstract submission system: cvent.com/c/abstracts/bc…

AHES is excited to be hosting Professor Emily Lancsar Emily Lancsar and Professor Prashant Bharadwaj for this year's AHES conference in Sydney.

Please submit your abstract before Sunday 12th May 2024. For further information, please visit our website: ahes.org.au/ahes-conferenc…

Delighted this important work on determining priority indicators of utility for genomic testing in rare disease is now published in Genetics in Medicine - Australian Genomics Economics of Genomics and Precision Medicine Unit

Meet the team: Daniel is a PhD candidate Economics of Genomics and Precision Medicine Unit. His research focuses on valuing preferences in genomic testing. He is currently focused on the health economics of additional findings in Australia. In his spare time, Daniel enjoys cooking, hiking, & board games.